Cannabinoid-induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis

European Journal of Pain

Volumn 13, Issue 5, 2009, Pages 472-477

  Conte, Antonella ^a,b   Bettolo, Chiara Marini ^a   Onesti, Emanuela ^a,d   Frasca, Vittorio ^a   Iacovelli, Elisa ^a   Gilio, Francesca ^a,c   Giacomelli, Elena ^a   Gabriele, Maria ^a   Aragona, Massimiliano ^a   Tomassini, Valentina ^a   Pantano, Patrizia ^a   Pozzilli, Carlo ^a   Inghilleri, Maurizio ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SANDRO PERTINI HOSPITAL   (Italy)

^d Neurological Centre of Latium   (Italy)

Author keywords

Cannabinoids; Multiple sclerosis; Nociceptive system; RIII reflex

Indexed keywords

CANNABIS; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; EUPHORIA; FATIGUE; FEMALE; FLEXOR REFLEX; HEADACHE; HOFFMANN REFLEX; HUMAN; MALE; MULTIPLE SCLEROSIS; NAUSEA AND VOMITING; NERVE STIMULATION; NEUROPHYSIOLOGY; NOCICEPTION; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLOWER THINKING; THOUGHT DISORDER; TIBIAL NERVE; VERTIGO; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; AFFERENT PATHWAYS; ANALGESICS; CANNABINOIDS; CENTRAL NERVOUS SYSTEM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NEURAL CONDUCTION; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PLACEBOS; REACTION TIME; REFLEX; TETRAHYDROCANNABINOL; TREATMENT OUTCOME;

EID: 63549096654     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.05.014     Document Type: Article

References (64)

1. Angel R.W., and Hoffmann W.W. The H reflex in normal, spastic and rigid subjects. Arch Neurol 8 (1963) 591-596
2. Arvidsson U., Dado R.J., Riedl M., Lee J.H., Law P.Y., Loh H.H., et al. delta-opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15 (1995) 1215-1235
3. Ashworth M.B. Preliminary trial of Carisprodol in multiple sclerosis. Practitioner (1964) 192-540
4. Baker D., Pryce G., Giovannoni G., and Thompson A.J. The therapeutic potential of cannabis. Lancet Neurol 2 (2003) 291-298
5. Bossard A.E., Guirimand F., Fletcher D., Gaude-Joindreau V., Chauvin M., and Bouhassira D. Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 98 (2002) 47-57
6. Boureau F., Willer J.C., and Albe-Fessard D. Role played in man by myelinated fibers of different diameters for the evocation of a nociceptive flex reflex and the accompanying pain sensation. C R Acad Sci Hebd Seances Acad Sci D 286 (1978) 1375-1378
7. Brady C.M., DasGupta R., Dalton C., Wiseman O.J., Berkley K.J., and Fowler C.J. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 10 Aug (2004) 425-433
8. Burke R.E. The use of state-dependent modulation of spinal reflexes as a tool to investigate the organization of spinal interneurons. Exp Brain Res 128 (1999) 263-277
9. Burns T.L., and Ineck J.R. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. Ann Pharmacother 40 (2006) 251-260
10. Campbell F.A., Tramer M.R., Carroll D., Reynolds D.J., Moore R.A., and McQuay H.J. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 323 (2001) 13-16
11. Collin C., Davies P., Mutiboko I.K., and Ratcliffe S for the Sativex Spasticity in MS Study Group. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol 14 (2007) 290-296
12. Dewey W.L. Cannabinoid pharmacology. Pharmacol Rev 38 (1986) 151-178
13. Docagne F., Mestre L., Loría F., Hernangómez M., Correa F., and Guaza C. Therapeutic potential of CB2 targeting in multiple sclerosis. Expert Opin Ther Targets 12 (2008) 185-195
14. Ertekin C., Ertekin N., and Karcioglu M. Conduction velocity along human nociceptive reflex afferent nerve fibres. J Neurol Neurosurg Psychiatry 38 (1975) 959-965
15. Gilbert P.E. A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal dog. Clin Pharmacol 21 (1981) 311S-319S
16. Herkenham M. Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections. NIDA Res Monogr 112 (1991) 129-145
17. Ho K., Spence J., and Murphy M.F. Review of pain-measurement tools. Ann Emerg Med 27 (1996) 427-432
18. Hohmann A.G. Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem Phys Lipids 121 (2002) 173-190
19. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69 Aug (2002) 619-631
20. Huskisson E.C. Measurement of pain. Lancet 2 (1974) 1127-1131
21. Iskedjian M., Bereza B., Gordon A., Piwko C., and Einarson T.R. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin 23 (2007) 17-24
22. Iversen L., and Chapman V. Cannabinoids: a real prospect for pain relief?. Curr Opin Pharmacol 2 (2002) 50-55
23. Jankowska E. Interneuronal relay in spinal pathways from proprioceptors. Prog Neurobiol 38 (1992) 335-378
24. Jankowska E. Spinal interneuronal systems: identification, multifunctional character and reconfigurations in mammals. J Physiol 533 (2001) 31-40
25. Kelly S., and Chapman V. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J Neurophysiol 86 (2001) 3061-3064
26. Kumazawa T., and Perl E.R. Excitation of marginal and substantia gelatinosa neurons in the primate spinal cord: indications of their place in dorsal horn functional organization. J Comp Neurol 177 (1978) 417-434
27. Kurtzke J.F. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
28. Mailleux P., and Vanderhaeghen J.J. Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci Lett 148 (1992) 173-176
29. Mao J., Price D.D., Lu J., Keniston L., and Mayer D.J. Two distinctive antinociceptive systems in rats with pathological pain. Neurosci Lett 280 (2000) 13-16
30. Nishioka K., Harada Y., Kitahata L.M., Tsukahara S., and Collins J.G. Role of WDR neurons in a hind limb noxious heat evoked flexion withdrawal reflex. Life Sci 56 (1995) 485-489
31. Page S.A., Verhoef M.J., Stebbins R.A., Metz L.M., and Levy J.C. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci. 30 Aug (2003) 201-205
32. Parise M., García-Larrea L., Mertens P., Sindou M., and Mauguière F. Clinical use of polysynaptic flexion reflexes in the management of spasticity with intrathecal baclofen. Electroencephalogr Clin Neurophysiol 105 (1997) 141-148
33. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74 (1997) 129-180
34. Pertwee R.G. Cannabinoid receptors and pain. Prog Neurobiol 63 (2001) 569-611
35. Pertwee R.G. Cannabinoids and multiple sclerosis. Pharmacol Ther 95 (2002) 165-174
36. Pertwee R.G., and Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66 (2002) 101-121
37. Rexed B. The cytoarchitectonic organization of the spinal cord in the cat. J Comp Neurol (1952)
38. Rog D.J., Nurmikko T.J., Friede T., and Young C.A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65 (2005) 812-819
39. Rossi A., and Decchi B. Flexibility of lower limb reflex responses to painful cutaneous stimulation in standing humans: evidence of load-dependent modulation. J Physiol 481 (1994) 521-532
40. Sagredo O., Ramos J.A., Fernandez-Ruiz J., Rodriguez M.L., and de Miguel R. Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 372 (2006) 313-317
41. Sandrini G., Alfonsi E., Bono G., Facchinetti F., Montalbetti L., and Nappi G. Circadian variations of human flexion reflex. Pain 25 (1986) 403-410
42. Sandrini G., Arrigo A., Bono G., and Nappi G. The nociceptive flexion reflex as a tool for exploring pain control systems in headache and other pain syndromes. Cephalalgia 13 (1993) 21-27
43. Sandrini G., Ruiz L., Capararo M., Danilov A., Beretta A., and Nappi G. Effects of dothiepin on nociceptive flexion reflex and diffuse noxious inhibitory controls in humans. Eur J Pharmacol 243 (1993) 99-102
44. Sandrini G., Serrao M., Rossi P., Romaniello A., Cruccu G., and Willer J.C. The lower limb flexion reflex in humans. Prog Neurobiol 77 (2005) 353-395
45. Schomburg E.D., Steffens H., and Mense S. Contribution of TTX-resistant C-fibres and Adelta-fibres to nociceptive flexor-reflex and non-flexor-reflex pathways in cats. Neurosci Res 37 (2000) 277-287
46. Schouenborg J., and Dickenson A. Effects of a distant noxious stimulation on A and C fibre-evoked flexion reflexes and neuronal activity in the dorsal horn of the rat. Brain Res 328 (1985) 23-32
47. Schouenborg J., and Kalliomaki J. Functional organization of the nociceptive withdrawal reflexes. I. Activation of hindlimb muscles in the rat. Exp Brain Res 83 (1990) 67-78
48. Shahani B.T., and Young R.R. Human flexor reflexes. J Neurol Neurosurg Psychiatry 34 (1971) 616-627
49. Smith P.F. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances. Expert Rev Neurother 7 Sep (2007) 1157-1163
50. Strasser F., Luftner D., Possinger K., Ernst G., Ruhstaller T., Meissner W., et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 24 (2006) 3394-3400
51. Svendsen K.B., Jensen T.S., and Bach F.W. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329 (2004) 253
52. Tassorelli C., Sandrini G., Cecchini A.P., Nappi R.E., Sances G., and Martignoni E. Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. Psychosom Med 64 (2002) 621-626
53. Tramer M.R., Carroll D., Campbell F.A., Reynolds D.J., Moore R.A., and McQuay H.J. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323 (2001) 16-21
54. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
55. Wade D.T., Makela P.M., House H., Bateman C., and Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler 12 (2006) 639-645
56. Walker J.M., Huang S.M., Strangman N.M., Tsou K., and Sañudo-Peña M.C. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci (USA) 96 (1999) 12198-12203
57. Willer J.C. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain 3 (1977) 69-80
58. Willer J.C. Nociceptive flexion reflexes as a tool for pain research in man. Adv Neurol 39 (1983) 809-827
59. Willer J.C. Studies on pain. Effects of morphine on a spinal nociceptive flexion reflex and related pain sensation in man. Brain Res 331 (1985) 105-114
60. Willer J.C., and Bussel B. Evidence for a direct spinal mechanism in morphine-induced inhibition of nociceptive reflexes in humans. Brain Res 187 (1980) 212-215
61. Willer J.C., De Broucker T., and Le Bars D. Encoding of nociceptive thermal stimuli by diffuse noxious inhibitory controls in humans. J Neurophysiol 62 (1989) 1028-1038
62. Yaksh T.L. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand 41 (1997) 94-111
63. You H.J., Dahl Morch C., Chen J., and Arendt-Nielsen L. Simultaneous recordings of wind-up of paired spinal dorsal horn nociceptive neuron and nociceptive flexion reflex in rats. Brain Res 960 (2003) 235-245
64. Zajicek J., Fox P., Sanders H., Wright D., Vickery J., Nunn A., et al., UK MS Research Group. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 362 (2003) 1517-1526